Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

Documenti analoghi

• Castration Resistance Accelerates Prostate Cancer Kinetics
  di: Sheila Jonnatan, et al.
  Pubblicazione: (2026)
• A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer
  di: Daniel Boiarsky, et al.
  Pubblicazione: (2024)
• Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients
  di: Tokiyoshi Tanegashima, et al.
  Pubblicazione: (2024)
• Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
  di: Tokiyoshi Tanegashima, et al.
  Pubblicazione: (2024)
• Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation
  di: Taro Igarashi, et al.
  Pubblicazione: (2024)